STOCK TITAN
  1. Home
  2. Sec-filings
  3. CDT
  4. [ARS] Conduit Pharmaceuticals Inc. SEC Filing

[ARS] Conduit Pharmaceuticals Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
ARS - Conduit Pharmaceuticals Inc.

ARS Filing - Conduit Pharmaceuticals Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Conduit Pharmaceuticals Inc. (CDT)

Acceptance Date: 2025-07-08T17:24:53.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock CDT logo
Conduit Pharms

NASDAQ:CDT

CDT Rankings

#10220 Ranked by Market Cap
N/A Ranked by Dividends

CDT Latest News

Jul 8, 2025
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
Jul 7, 2025
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
Jun 4, 2025
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
May 22, 2025
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
May 21, 2025
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

CDT Latest SEC Filings

Jul 9, 2025
[DEF 14A] Conduit Pharmaceuticals Inc. Definitive Proxy Statement

CDT Stock Data

2.78M
773.60k
13.92%
2.41%
9.58%
Biotechnology
Pharmaceutical Preparations
Link
United States
NAPLES